Cargando…

ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis

Background: Drug repositioning is considered a promising drug development strategy with the goal of discovering new uses for existing drugs. Compared with the experimental screening for drug discovery, computational drug repositioning offers lower cost and higher efficiency and, hence, has become a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mengyun, Yang, Bin, Duan, Guihua, Wang, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545866/
https://www.ncbi.nlm.nih.gov/pubmed/37795241
http://dx.doi.org/10.3389/fgene.2023.1271311
_version_ 1785114754222653440
author Yang, Mengyun
Yang, Bin
Duan, Guihua
Wang, Jianxin
author_facet Yang, Mengyun
Yang, Bin
Duan, Guihua
Wang, Jianxin
author_sort Yang, Mengyun
collection PubMed
description Background: Drug repositioning is considered a promising drug development strategy with the goal of discovering new uses for existing drugs. Compared with the experimental screening for drug discovery, computational drug repositioning offers lower cost and higher efficiency and, hence, has become a hot issue in bioinformatics. However, there are sparse samples, multi-source information, and even some noises, which makes it difficult to accurately identify potential drug-associated indications. Methods: In this article, we propose a new scheme with improved tensor robust principal component analysis (ITRPCA) in multi-source data to predict promising drug–disease associations. First, we use a weighted k-nearest neighbor (WKNN) approach to increase the overall density of the drug–disease association matrix that will assist in prediction. Second, a drug tensor with five frontal slices and a disease tensor with two frontal slices are constructed using multi-similarity matrices and an updated association matrix. The two target tensors naturally integrate multiple sources of data from the drug-side aspect and the disease-side aspect, respectively. Third, ITRPCA is employed to isolate the low-rank tensor and noise information in the tensor. In this step, an additional range constraint is incorporated to ensure that all the predicted entry values of a low-rank tensor are within the specific interval. Finally, we focus on identifying promising drug indications by analyzing drug–disease association pairs derived from the low-rank drug and low-rank disease tensors. Results: We evaluate the effectiveness of the ITRPCA method by comparing it with five prominent existing drug repositioning methods. This evaluation is carried out using 10-fold cross-validation and independent testing experiments. Our numerical results show that ITRPCA not only yields higher prediction accuracy but also exhibits remarkable computational efficiency. Furthermore, case studies demonstrate the practical effectiveness of our method.
format Online
Article
Text
id pubmed-10545866
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105458662023-10-04 ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis Yang, Mengyun Yang, Bin Duan, Guihua Wang, Jianxin Front Genet Genetics Background: Drug repositioning is considered a promising drug development strategy with the goal of discovering new uses for existing drugs. Compared with the experimental screening for drug discovery, computational drug repositioning offers lower cost and higher efficiency and, hence, has become a hot issue in bioinformatics. However, there are sparse samples, multi-source information, and even some noises, which makes it difficult to accurately identify potential drug-associated indications. Methods: In this article, we propose a new scheme with improved tensor robust principal component analysis (ITRPCA) in multi-source data to predict promising drug–disease associations. First, we use a weighted k-nearest neighbor (WKNN) approach to increase the overall density of the drug–disease association matrix that will assist in prediction. Second, a drug tensor with five frontal slices and a disease tensor with two frontal slices are constructed using multi-similarity matrices and an updated association matrix. The two target tensors naturally integrate multiple sources of data from the drug-side aspect and the disease-side aspect, respectively. Third, ITRPCA is employed to isolate the low-rank tensor and noise information in the tensor. In this step, an additional range constraint is incorporated to ensure that all the predicted entry values of a low-rank tensor are within the specific interval. Finally, we focus on identifying promising drug indications by analyzing drug–disease association pairs derived from the low-rank drug and low-rank disease tensors. Results: We evaluate the effectiveness of the ITRPCA method by comparing it with five prominent existing drug repositioning methods. This evaluation is carried out using 10-fold cross-validation and independent testing experiments. Our numerical results show that ITRPCA not only yields higher prediction accuracy but also exhibits remarkable computational efficiency. Furthermore, case studies demonstrate the practical effectiveness of our method. Frontiers Media S.A. 2023-09-18 /pmc/articles/PMC10545866/ /pubmed/37795241 http://dx.doi.org/10.3389/fgene.2023.1271311 Text en Copyright © 2023 Yang, Yang, Duan and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Yang, Mengyun
Yang, Bin
Duan, Guihua
Wang, Jianxin
ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title_full ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title_fullStr ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title_full_unstemmed ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title_short ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis
title_sort itrpca: a new model for computational drug repositioning based on improved tensor robust principal component analysis
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545866/
https://www.ncbi.nlm.nih.gov/pubmed/37795241
http://dx.doi.org/10.3389/fgene.2023.1271311
work_keys_str_mv AT yangmengyun itrpcaanewmodelforcomputationaldrugrepositioningbasedonimprovedtensorrobustprincipalcomponentanalysis
AT yangbin itrpcaanewmodelforcomputationaldrugrepositioningbasedonimprovedtensorrobustprincipalcomponentanalysis
AT duanguihua itrpcaanewmodelforcomputationaldrugrepositioningbasedonimprovedtensorrobustprincipalcomponentanalysis
AT wangjianxin itrpcaanewmodelforcomputationaldrugrepositioningbasedonimprovedtensorrobustprincipalcomponentanalysis